The dissolution profile of inhaled drugs underpins therapeutic efficacy and is an area of increasing regulatory scrutiny, particularly for the demonstration of bioequivalence in a generic. The new ...
Teva is voluntarily recalling a single lot of Anagrelide Capsules, USP 0.5mg, due to dissolution failure that was detected during a routine stability test. Teva is voluntarily recalling a single lot ...
The Kathmandu Post on MSN
DDA took 11 months to test substandard drug. Patients may have already taken it
The Department of Drug Administration (DDA) has recalled a third-generation antibiotic, Levoflox-500 tablet, after the ...
The 13th Annual International Symposium on Dissolution Science and Applications – DISSO INDIA 2025, organized by the Society for Pharmaceutical Dissolution Science (SPDS), in collaboration with SVKM's ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the introduction of the NanoDis System for nanoparticle dissolution testing. Combining Agilent instrumentation ...
The British Pharmacopoeia on Monday released its response to its consultation on dissolution testing and announced its plans to update its approach within its product monographs. The British ...
Rockville, Md., April 1, 2008 — The U.S. Pharmacopeial (USP) Convention today announced results of a study comparing the dissolution variability of USP Prednisone Lot P Reference Standard tablets to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback